Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational PolicyBlue Cross Blue Shield TX Prior Auth Policy Update…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ModifiedBlue Cross Blue Shield - TexasPolicy N/A

    2025 Commercial Prior Authorization Codes for Administrative Services

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - Texas policy alerts

    Know when Blue Cross Blue Shield - Texas releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Governs the list of CPT/HCPCS codes and associated administrative prior authorization requirements and management contacts for commercial members (including TDI-identified fully insured members) effective 01/01/2025. Affects providers submitting prior auth requests and internal utilization management teams.

    Policy Summary
    PayerBlue Cross Blue Shield - Texas
    Policy2025 Commercial Prior Authorization Codes for Administrative Services
    Policy CodePolicy N/A
    Change TypeMultiple material updates (site-of-care additionvendor/management assignmentscode additions/removals)
    Effective DateJan 1, 2025
    Next Review DateN/A
    Key ActionProviders must obtain prior authorization using the searchable list, Blue Approve, or the phone number on the member ID card and route requests to the named manager (Carelon or Alacura) where indicated.
    SourceLink
    POLICY UPDATE CHANGES

    Addition of site of care to the medical necessity criteria for numerous advanced imaging CPT codes, effective 01/01/2025.

    Update Category name from "Non-Emergent Air Ambulance" to "Medical Transportation" effective 01/01/2025 and services management changed from BCBSTX to Alacura for certain ambulance codes.

    Multiple molecular genetic lab testing codes (0552U - 0571U and many 8xxxx series) were added with Carelon as manager and effective dates (most 10/01/2025 or 04/01/2025).

    01/01/2025effective date for site-of-care addition
    01/01/2025
    effective date for Medical Transportation change
    Carelondesignated prior authorization vendor
    ~120+approx. advanced imaging CPTs listed
    ~200+molecular genetic/PLA/U codes listed (segment)

    Coverage, Medical Necessity and Prior Authorization Criteria

    Coverage and prior authorization guidance (partial)

    Presence of a code on this list does not necessarily indicate coverage; member benefits determine coverage. Prior authorization may be required for listed services.

    The presence of a CPT/HCPCS code on the payer's prior authorization list does not by itself guarantee coverage; verify member benefits or the member benefit booklet to determine coverage for a specific service.

    Prior authorization + site-of-care medical necessity requirement

    Prior authorization and medical necessity determinations for listed CPT codes now require consideration of site of care (effective 01/01/2025).

    Prior authorization is required for the listed advanced imaging and related CPT codes and medical necessity determinations must include the site of care (addition effective 01/01/2025).

    Designated prior authorization vendor for many listed codes is Carelon; follow the payer's submission process.

    Prior authorization requirement for listed CPT codes

    Provider must obtain prior authorization from the designated reviewer before scheduling or performing the services listed below.

    Prior authorization is required for the enumerated imaging, cardiology and echocardiography CPT codes before scheduling or performance; many entries are routed to Carelon for review.

    Consult the full code list and vendor mapping for code-level routing information.

    Prior authorization code groups

    Grouped code sets and their designated prior-authorization managers as shown in the excerpt.

    Advanced imaging/cardiology: Echocardiography and advanced imaging codes (examples include 93314–93317, 93320–93321, 93325, 93350–93352, 0042T, 0633T–0638T, A9602, A9800, C8900) require prior authorization.

    Vendor indicated for many entries: Carelon.

    ENT / Cochlear / Rhinoplasty: ENT procedures and cochlear implant procedure/supply codes (examples: 30120, 30400–30450 series, 69714, 69930, L8614–L8629, L8690–L8693) require prior authorization.

    Vendor indicated for these entries: BCBSTX.

    Gastroenterology / Home infusion / Neurostimulator: Gastroenterology and home infusion related codes (examples: 36516, S2120, E0765, S5501–S5502, S9208–S9214, S9325) require prior authorization.

    Vendor indicated for these entries: BCBSTX.

    Home infusion prior authorization and billing notes

    Home infusion services require prior authorization and have specific billing/per‑diem or hourly rules.

    Home infusion and related HCPCS codes listed (examples: S9211, S9213, S9214, S9325, S9357, S9359, S9372, S9373, S9375, S9376, S9494, S9497, S9500–S9502, S9590, S9810) require prior authorization before billing or scheduling.

    Per-diem codes (e.g., S9325, S9373, S9494) are billed per day as specified; S9810 is per hour and should not be used with per‑diem codes. Do not combine per‑diem codes when guidance prohibits it (see code-specific notes). Vendor mapping: BCBSTX for many home infusion entries.

    Medical transportation management change

    Category and management changes for certain medical transportation codes effective 01/01/2025.

    Medical transportation codes A0430, A0435 and S9960 are now classified under the category 'Medical Transportation' (previously 'Non-Emergent Air Ambulance') and services management for these codes changed to Alacura effective 01/01/2025.

    Prior authorization/process for these codes may now be handled by Alacura (call center information provided in the source).

    Molecular genetic testing prior authorization and management

    Numerous molecular genetic U-codes and 8xxxx series codes require prior authorization and have vendor/administrative assignments and effective dates.

    Many molecular genetic test billing codes (including new/added U-codes such as 0552U–0571U and numerous 8xxxx CPT codes) require prior authorization; Carelon is identified as the prior-authorization manager for the majority of these entries.

    Several U-codes show 'Add effective' dates (primarily 10/01/2025) and select 8xxxx codes include effective dates; verify code-specific effective/retire dates before submission.

    Prior authorization – molecular genetic testing

    Gene-specific molecular CPT codes and mappings that require prior authorization; vendor indicated where provided.

    Prior authorization is required for the listed molecular genetic CPT codes (examples in the range 81203–81292 and others); many entries note Carelon as the review vendor and include brief gene/test mapping or clinical context.

    See the full code list for detailed gene/test mappings and specimen/methodology information.

    Prior authorization required codes

    Specific molecular genetic CPT codes require prior authorization and are associated with gene/test descriptions.

    Listed molecular genetic CPT codes (sample series including 81285–81364 and 81400 and others) require prior authorization through the designated reviewer (Carelon where indicated).

    Providers must request prior authorization for these CPTs prior to performing or billing services.

    Prior authorization and procedure-level mapping

    Molecular pathology procedure-level mapping and prior authorization requirement.

    Prior authorization is required for molecular pathology procedure codes (CPT 81400–81410 and related levels). Procedure level selection should follow the document's mapping (levels reflect scope such as single-variant detection through large exon/gene panels).

    Carelon is referenced as the prior-authorization administrator for multiple CPTs in this segment; follow payer-specified submission processes.

    Assign molecular pathology procedure level based on analytic scope (examples in the source: level 2 = 2–10 targeted variants/SNPs, level 3 = >10 SNPs or rearrangement/LOH/UPD analyses, level 4 = single exon or >10 amplicons, etc.).see source mapping

    Use the procedure-level thresholds provided in the policy when submitting authorizations and coding claims.

    Prior authorization requirements for molecular genetic testing

    Prior authorization requirements for listed molecular genetic and gene‑expression CPT codes; panel composition requirements when applicable.

    Prior authorization is required for the enumerated molecular genetic and gene-expression CPT codes; where panels are described, the genomic sequence analysis panel must include at least the minimum number of genes specified for that code (examples in the source: panels requiring ≥10, ≥15, ≥60 genes, etc.).

    Duplication/deletion panels must include named genes when specified (examples: BRCA1/2, MLH1/MSH2, etc.).

    Operational notes

    • Carelon is the named authorization entity for many codes — route prior authorization requests to Carelon where indicated.
    • Some codes are marked for retirement or have add-effective dates (verify effective/retire dates prior to submission).

    Prior Authorization Criteria - code list

    Representative molecular genetic and gene-expression tests requiring prior authorization; many entries include methodology and reporting format.

    Prior authorization is required for listed molecular genetic/PLA/PLA-range codes (examples: 81522, 81523, 81525, 81529, 81540, 81541, 81542, 81558, 81595, 0055U, 0087U, 0088U and others).

    Entries commonly include the clinical area (oncology, transplant, cardiology, etc.), assay method (RT-PCR, NGS, microarray) and reporting format (recurrence score, categorical risk, percent donor-derived cfDNA).

    Carelon is identified as the reviewer/manager for the majority of these molecular genetic entries; follow Carelon routing where specified.

    Prior authorization list

    Enumerated U-codes and PLA-style molecular genetic test codes that require prior authorization.

    The enumerated PLA/U and U-code molecular genetic test billing codes (examples include 0114U, 0118U, 0120U, 0129U, 0130U, 0267U, 0306U, J0266U and many others shown in the coding list) require prior authorization through the designated reviewer (Carelon for most entries).

    Clinical indications and specimen types vary by code; consult the code-specific entry for clinical context and effective/add dates.

    Prior authorization requirement

    Tests listed in this segment require prior authorization through Carelon.

    Multiple molecular genetic test codes in this segment (including J0266U, 0267U, 0268U, 0269U, 0270U, 0271U, 0272U, etc.) are designated to be reviewed by Carelon and require prior authorization before performance or billing.

    Providers should route authorizations to Carelon per payer instructions.

    Code retirement notices

    Certain PLA/U codes have scheduled retirement actions noted in the policy.

    Specific PLA/U codes are marked with retirement effective dates (examples provided in the source: 0380U retire effective 04/01/2025; 0396U retire effective 07/01/2025).

    Verify current code applicability and effective/retire dates prior to submission or billing.

    Prior authorization requirements and administrative notes

    Administrative notes and vendor assignments for molecular genetic tests; check code‑level effective/retire dates.

    Prior authorization is required for each listed molecular genetic code and Carelon is designated as the prior-authorization manager for many entries in this section.
    Several codes include administrative timing notes such as 'Add effective' or 'Retire Effective' with 2025 dates; verify the effective date for authorization and billing workflows before submission.

    Authorization-required codes (partial list)

    Partial list of authorization-required codes with examples and vendor routing.

    Selected U/PLA and other molecular genetic codes in this excerpt require prior authorization; many are routed to Carelon. Examples in this segment include 0497U, 0498U, 0500U, 0538U, 0627T, 20930 and 22513.

    Specific clinical criteria are code-dependent; consult the detailed entry for the code for clinical and effective-date guidance.

    Prior authorization list (excerpt)

    Musculoskeletal and spine procedure codes require prior authorization and are assigned to the designated reviewer.

    Selected musculoskeletal and spine CPT codes (examples: 22515, 22532, 22533, 22534, 23473, 23474, 27096, 27120, 27134, 27137, 27138, 27279) require prior authorization before services are performed; many entries are routed to Carelon for review.

    When additional interspaces or segments are performed, list each additional interspace/segment separately as instructed in the policy.

    Procedure and Billing Codes (CPT / HCPCS / U / PLA) Requiring Prior Authorization

    Advanced Imaging / Radiology codes (partial)CPTCovered
    70336Magnetic Resonance Imaging Temporomandibular Joint(s)
    70450Computed Tomography Head or Brain; Without Contrast Material
    70460Computed Tomography Head or Brain; With Contrast Material
    Selected advanced imaging/cardiology CPT codes requiring prior authorizationCPTCovered
    73206Computed Tomographic Angiography Upper Extremity With Contrast Material (includes noncontrast images if performed) and related MRI/CT upper extremity codes referenced
    73218Magnetic Resonance Imaging Upper Extremity Other Than Joint; Without Contrast
    73219Magnetic Resonance Imaging Upper Extremity Other Than Joint; With Contrast
    73220Magnetic Resonance Imaging Upper Extremity Other Than Joint; Without Contrast Followed By Contrast
    73701Computed Tomography Lower Extremity; With Contrast
    74160Computed Tomography Abdomen (various variants) / related abdomen CT/MR codes
    75571Computed Tomography Heart Without Contrast (coronary calcium)
    76376Rendering with interpretation and reporting with image postprocessing (CT/MR/US)
    77046Magnetic Resonance Imaging Breast Without Contrast; Unilateral
    78430Myocardial Imaging PET Perfusion Study (single study) with CT transmission
    Imaging and Cardiology CPT codes requiring prior authorizationCPTCovered
    78266Multiple Days (radiopharmaceutical imaging)
    78278Acute Gastrointestinal Blood Loss Imaging
    78290Intestine Imaging (Eg Meckel's localization)
    78291Peritoneal-Venous Shunt Patency Test
    78300Bone and/or Joint Imaging; Limited Area
    78305Bone and/or Joint Imaging; Multiple Areas
    78306Bone and/or Joint Imaging; Whole Body
    78315Bone and/or Joint Imaging; 3 Phase Study
    78429Myocardial PET metabolic evaluation with CT transmission scan
    78430Myocardial PET perfusion single study with CT
    1–10 of 85
    1/9
    Advanced imaging / EchocardiographyCPTCovered
    93350-93352Transthoracic echocardiography with stress and contrast (various)
    0042TCerebral perfusion analysis using CT with contrast
    0633T-0638TComputed tomography breast codes (unilateral/bilateral; with/without contrast)
    ENT / CochlearCPT | HCPCSCovered
    30400-30450Rhinoplasty primary and secondary procedure codes
    69714,69930,L8614-L8629,L8690-L8693Cochlear implant procedure and supply/device codes
    Home infusion and related HCPCS codesHCPCSCovered
    S9211Home Infusion Therapy; electronic analysis of implanted neurostimulator pulse generator system / home management entries
    S9213Home Infusion Therapy; home management of postpartum/gestational hypertension/ preeclampsia entries
    S9325Home infusion therapy management; administrative services per diem
    S9373Home infusion therapy; hydration therapy per diem
    S9494Home infusion therapy; antibiotic/antiviral/antifungal per diem
    S9810Home therapy; professional pharmacy services per hour (not per diem)
    Molecular genetic lab testing codes (U-codes and 8xxxx series)mixedCovered
    0552UReproductive medicine preimplantation genetic assessment — analysis for known genetic disorders from trophectoderm biopsy
    0553UPreimplantation genetic assessment; 24 chromosome analysis
    0560UOncology MRD genomic sequence analysis baseline assessment
    0571UOncology (solid tumor); DNA and RNA panel by NGS, plasma
    81120IDH1 common variants
    81162BRCA1/BRCA2 full sequence and duplication/deletion analysis
    81170ABL1 kinase domain variant analysis
    Medical transportation/air ambulance codesHCPCSCovered
    A0430Ambulance service conventional air services transport one way (fixed wing)
    A0435Fixed wing air mileage
    S9960Ambulance service, conventional air service, nonemergency transport, one way (fixed wing)
    Molecular genetic testing CPT rangeCPT | mixed
    81203-81292Molecular genetic laboratory testing codes mapping to specific gene analyses (gene-specific tests and variants listed across entries)
    Listed molecular genetic CPT codesCPT
    81285-81400+Wide range of molecular genetic and molecular pathology CPT codes listed (examples include 81285-81364, 81400 and many others) as requiring prior authorization.
    molecular pathology CPT groupsCPT | mixedCovered
    81400Molecular genetic lab testing / molecular pathology procedure level (single variant identification examples listed)
    81401Molecular pathology procedure level 2 (2–10 SNPs, methylation or somatic variant detection examples)
    81402Molecular pathology procedure level 3 (>10 SNPs, immunoglobulin/T-cell receptor rearrangements, LOH/UPD)
    81403Molecular pathology procedure level 4 (single exon sequencing, >10 amplicons, mutation scanning)
    81404Molecular pathology procedure level 5 (analysis of 2–5 exons by DNA sequence analysis)
    81405Molecular pathology procedure level 6 (analysis of 6–10 exons; regionally targeted cytogenomic analysis)
    81406Molecular pathology procedure level 7 (analysis of 11–25 exons by DNA sequence analysis)
    81407Molecular pathology procedure level 8 (analysis of 26–50 exons or >50 exons / large panels)
    81410Molecular pathology procedure (exons in single gene by DNA sequence analysis / full gene sequencing)
    Representative molecular genetics and gene-expression CPT codes requiring authorizationCPTCovered
    81410Molecular genetic lab testing / full gene and sequence analyses (examples listed)
    81415Exome sequence analysis
    81430Hearing loss panel (≥60 genes)
    81432Hereditary breast cancer-related disorders panel (≥10 genes including BRCA1/2)
    81518Oncology (breast) mRNA gene expression profiling, 11 genes
    81540Oncology tumor of unknown origin mRNA profiling, 92 genes
    Representative molecular/gene expression CPT/PLA codesmixed
    81522Gene expression profiling by RT-PCR of 12 genes reported as recurrence risk score
    81523mRNA NGS gene expression profiling of 70 content genes reported as index related to risk to distant metastasis
    81525mRNA gene expression profiling by real-time RT-PCR of 12 genes (colon) reported as a recurrence score
    81529mRNA gene expression profiling by real-time RT-PCR of 31 genes (cutaneous melanoma) reported as recurrence risk including likelihood of sentinel lymph node metastasis
    Transplant and heart-related PLA codesmixed
    0055UCardiology (Heart Transplant) cell-free DNA PCR assay of 96 DNA target sequences (plasma)
    0087UmRNA gene expression profiling by microarray of 1283 genes for heart transplant allograft rejection
    0088Umicroarray gene expression profiling of 1494 genes for kidney allograft rejection
    Molecular genetic / U-codes requiring prior authorizationmixedCovered
    0114UMolecular genetic lab testing (various specific assays)
    0118U
    0120U
    0129U
    0130U
    0131U
    0132U
    0133U
    0134U
    10135U
    1–10 of 67
    1/7
    Examples of PLA/U molecular genetic test codes in this segmentmixed
    J0266UMolecular genetic lab testing — unexplained constitutional or other heritable disorders; tissue-specific gene expression by whole-transcriptome and NGS
    0267UMolecular genetic lab testing — identification of structural variants by optical genome mapping and whole genome sequencing
    0306UOncology MRD NGS targeted sequencing analysis cell-free DNA initial assessment
    0326UTargeted genomic sequence analysis panel (83+ genes) for solid organ neoplasm
    Codes with retirement actionsmixed
    0380UListed as 'Retire Effective 04/01/2025'
    0396UListed as 'Retire Effective 07/01/2025'
    selected U-codes and J-codes appearing in this segmentmixed
    0392UGene-drug interactions variant analysis of 16 genes including CYP2D6 deletion/duplication
    0396URepeat expansion variant analysis; various genomic testing descriptions (Retire Effective 07/01/2025 indicated)
    0401UExpanded carrier screening / cardiology genetic risk score (9 genes) and other assays
    0411UGenomic analysis panel (15 genes) for psychiatry including CYP2D6
    0449UCarrier screening panel must include CFTR, SMN1, HBB, HBA1, HBA2
    J0428UCirculating tumor DNA targeted hybrid-capture panel (56+ genes) - Carelon; marked retire 04/01/2025
    0489UNoninvasive prenatal fetal antigen and single-gene NIPT; 'Add effective 07/01/2025' noted
    Selected molecular/genetic and NGS codesCPT | HCPCS | mixedCovered
    0497UGene-expression profiling by RT-PCR for prostate cancer (6 genes) reported as risk score
    0498UCell-free DNA fetal antigen noninvasive prenatal test; detection of fetal antigens (Rh, C, D, E, Duffy, Kell)
    0500UUBA1 gene mutation targeted variant analysis (VEXAS)
    0538UNGS targeted sequencing of 600 genes for solid tumors
    Musculoskeletal/spine procedure codesCPT | HCPCS | mixedCovered
    0627TPercutaneous injection of allogeneic cellular/tissue-based product, intervertebral disc; first level
    20930Allograft morselized or osteopromotive material for spine surgery
    22513Percutaneous vertebral augmentation (kyphoplasty) thoracic
    Selected CPT codes requiring prior authorization (excerpt)CPTCovered
    22515Percutaneous vertebral augmentation (e.g., kyphoplasty)
    22532Arthrodesis lateral extracavitary technique; thoracic
    22533Arthrodesis lateral extracavitary technique; lumbar
    22600Arthrodesis posterior or posterolateral technique; single interspace; cervical below C2
    22856Total disc arthroplasty, cervical, single interspace
    27130Total hip arthroplasty
    List exhaustiveness note
    ExhaustivenessLists are not exhaustive; presence of a code on this list does not guarantee coverage — consult the member benefit booklet or customer service to confirm coverage.
    ScopeIncludes CPT and HCPCS codes for services/categories that may require prior authorization as of 01/01/2025 (except where an alternate effective/retire date is shown).

    How Providers Request Authorization and Operational Notes

    Prior Authorization

    Prior Authorization Required for Listed Imaging and Cardiology CPT Codes (Carelon)

    Prior authorization is required for the imaging and cardiology CPT codes listed in this section. These requests are managed by Carelon (Carelon Clinical Review). Submit prior authorization requests through the payer’s designated portals (Blue ApprovrSM), by phone using the number on the member ID card, or via the vendor-specific instructions. Effective 2025-01-01, site-of-care additions and vendor assignments (Carelon) apply to listed advanced imaging and cardiology codes.

    • Managed by Carelon (vendor) for advanced imaging and cardiology CPTs
    • Request methods: Blue ApprovrSM portal, phone (member ID card), or vendor portal as directed
    • Effective date: 2025-01-01 (site-of-care criteria additions)
    Prior Authorization

    Prior Authorization for Echocardiography and Doppler Procedures

    Transthoracic, transesophageal, and Doppler echocardiography codes require prior authorization and are managed by Carelon. This includes complete, limited, congenital, stress, and Doppler add-on studies. Ensure authorization is obtained before scheduling.

    Definitions and Vendor / Term References

    Indicator on member ID card for Fully Insured Members
    Member ID indicator'TDI' will be indicated on the member's ID card for Fully Insured Members.
    UseProviders should reference the member ID card to determine fully insured status when initiating prior authorization workflows.
    ReferenceInformation appears in the introductory note of the prior authorization list (Effective 1/1/2025).
    Designated prior authorization vendor for the listed CPT codes
    Designated vendorCarelon is the designated prior authorization reviewer for the listed advanced imaging and cardiology CPT codes.
    ExamplesCodes routed to Carelon include 78266, 78429, 78430, and numerous PET/SPECT and cardiac imaging CPTs referenced in the imaging sections.
    Policy Summary
    PayerBlue Cross Blue Shield - Texas
    Policy2025 Commercial Prior Authorization Codes for Administrative Services
    Policy CodePolicy N/A
    Change TypeMultiple material updates (site-of-care additionvendor/management assignmentscode additions/removals)
    Effective DateJan 1, 2025
    Next Review DateN/A
    Key ActionProviders must obtain prior authorization using the searchable list, Blue Approve, or the phone number on the member ID card and route requests to the named manager (Carelon or Alacura) where indicated.
    SourceLink
    On This Page
    Coverage, Medical Necessity and Prior Authorization CriteriaProcedure and Billing Codes (CPT / HCPCS / U / PLA) Requiring Prior AuthorizationHow Providers Request Authorization and Operational NotesDefinitions and Vendor / Term References
    Action
    Providers must verify member-specific benefits prior to scheduling or billing; use the searchable PDF or contact prior authorization per instructions in the document.
    site_of_care_requirement_effective_date
    Effective dateSite-of-care added to medical necessity criteria effective 01/01/2025.
    Affected codesNumerous advanced imaging CPT codes (examples: 70450, 70460, 73206, 74182) reference this change in their 'Updates' field.
    Operational impactSite of care must be considered when determining medical necessity for listed CPT codes beginning 01/01/2025.
    Multi-day imaging indicator
    IndicatorSome radiopharmaceutical/localization CPTs distinguish single-day imaging versus multi-day imaging (e.g., 78802 = planar whole body single imaging day; 78804/78831 entries reference multi-day acquisitions).
    ExamplesCodes such as 78266 and 78831 include 'Multiple Days' or 'Single Day/Acquisition Over 2 or More Days' qualifiers in their descriptions.
    Vendor mappingCarelon is identified as the manager/reviewer for many multi-day imaging codes where specified.
    code retirement note
    Retirement note92633 is marked 'Retire Effective 01/01/2025' in the list.
    Related entriesRetirement entries for device/ENT codes are shown alongside BCBSTX management mapping.
    Provider actionVerify current applicability before submission when a code is marked for retirement.
    Hydration volume thresholds
    Thresholds by codeS9373/S9375/S9376 define hydration per-diem categories by administered volume: S9373 (hydration per diem unspecified volume baseline), S9375 (>1 L up to 2 L per day), S9376 (>2 L up to 3 L per day).
    Billing guidanceDo not use certain hydration per-diem codes together when daily volume scales are specified (per code notes).
    ManagementMapped to BCBSTX for authorization in the listed entries.
    panel size thresholds
    Procedure-level mappingMolecular pathology procedure levels map to variant/exon scope: Level 2 = 2–10 SNPs or targeted analyses; Level 3 = >10 SNPs or 2–10 methylated/ somatic variants (includes UPD/LOH/STR); Level 4 = single exon or >10 amplicons; Level 5 = 2–5 exons; Level 6 = 6–10 exons; Level 7 = 11–25 exons; Level 8 = 26–50 exons or >50 exons/large panels.
    UseSelect the molecular pathology procedure level consistent with the number/type of variants or exons interrogated for the assay.
    Auth vendorCarelon is referenced for many procedure-level CPT mappings.
    minimum genes required in panels
    Minimum genes examplesDocument specifies minimum gene counts for genomic panels (examples include panels requiring sequencing of at least 9, 10, 12, 15, 30, 60, or 100 genes depending on the code).
    Code-specific requirementExamples: 81412 requires sequencing of at least 9 genes; 81413 requires at least 10 genes; 81434 requires at least 15 genes; 81470/81471 require sequencing/analysis of at least 60 genes; other entries require ≥100 genes for certain mitochondrial/nuclear panels.
    Authorization noteCarelon is listed as the reviewer for many panels with minimum-gene requirements; prior authorization must document panel content to meet the stated minimums.
    panel/gene counts mentioned
    Range of panel sizesTests in the document range from single-gene assays up to whole exome/genome and panels of up to 505 genes (examples and large-panel codes listed).
    ExamplesRepresentative large panels include NGS panels and PLA/U entries interrogating hundreds of genes (document lists panels with 51, 92, 145, 517, 600+ gene examples).
    ImplicationPanel selection and prior authorization should reference the stated gene-count or exome/genome scope for correct procedure-level coding and review routing.
    Carrier panel gene requirement
    Carrier panel requirementFor carrier screening (0449U) the genomic sequence analysis panel must include analysis of CFTR, SMN1, HBB, HBA1, and HBA2.
    ContextThis requirement applies regardless of race or self-identified ancestry per the listed entry for expanded carrier screening.
    Authorization mapping0449U is routed to Carelon for prior authorization review in the listed entries.
    Effective add dates
    Add/retire effective datesSeveral codes display explicit 'Add effective' or 'Retire Effective' dates between 04/01/2025 and 10/01/2025 (examples: many U-codes add effective 10/01/2025; select U-codes add effective 07/01/2025; some codes retire 04/01/2025).
    Examples0552U–0555U and many 0560U-series show 'Add effective 10/1/2025'; 0500U/0506U/0508U show 'Add effective 07/01/2025'; 0380U marked 'Retire Effective 04/01/2025'.
    Provider actionConfirm the effective/retire dates in authorization and billing workflows to ensure correct routing and claim processing.
    Additional interspace/segment reporting
    Reporting instructionWhen applicable for spine procedures, each additional vertebral segment or interspace must be listed separately in addition to the primary procedure code (e.g., 'Each Additional Interspace/Segment').
    ExamplesCodes such as 22515, 22532–22534, 22612, 22630–22633 reference listing additional interspaces/segments separately in the entry notes.
    Billing implicationSubmit additional interspace/segment line items where required to reflect the complete surgical scope for prior authorization and claims review.
    • Examples of affected CPTs include: 93303, 93304, 93306, 93307, 93314–93317, 93320–93321, 93325, 93350–93351
    Prior Authorization

    Echocardiography and Advanced Imaging Prior Authorization

    Echocardiography and advanced imaging studies (CT, MRI, PET and related procedures) listed in this section require prior authorization through Carelon. Site-of-care criteria updates effective 2025-01-01 may affect medical necessity determinations. Obtain authorization prior to service to avoid denials.

    • Advanced imaging categories: CT, MRI, PET, related add-on and modality-specific CPTs
    • Carelon is the managing vendor for listed advanced imaging CPTs
    • Site-of-care criteria added effective 2025-01-01
    Prior Authorization

    ENT / Cochlear / Rhinoplasty Prior Authorization

    ENT procedures including rhinoplasty codes, cochlear implant procedures, osseointegrated implant codes, and related ENT surgical/endoscopic procedures require prior authorization. Many of these services are managed directly by BCBSTX for ENT-specific items; check the listed assignments and obtain prior authorization before scheduling.

    • Affected examples: 30120; 30400, 30410, 30420, 30430, 30435, 30450; 30999; 31296–31299; cochlear implant codes 69930, L8614, L8615; osseointegrated implant codes 69714, 69717
    Prior Authorization

    Gastroenterology / Home Infusion / Neurostimulator Prior Authorization

    Gastroenterology services, home infusion therapy per-diem codes, and implanted neurostimulator/neuromodulation device services require prior authorization. Home infusion management and certain neurostimulator services are managed by BCBSTX; specific codes may have vendor assignments as listed.

    • Gastroenterology and neurostimulator examples: E0765 (gastric neurostimulator intraoperative programming)
    • Home infusion per-diem codes: S5501, S5502, S9208, S9209, S9211, S9213, S9214, S9325 (BCBSTX-managed)
    • Obtain prior authorization before initiating home infusion or implanted neurostimulator procedures
    Prior Authorization

    Prior Authorization Required for Listed Molecular Pathology and Genetic Tests

    A broad list of molecular pathology and molecular genetic CPTs and proprietary test codes require prior authorization and are routed to Carelon for review. This includes single-gene tests, multi-gene panels, genomic sequencing assays, transplant monitoring assays, oncology panels, and many newer U- and number-series codes. Verify vendor routing and obtain authorization prior to ordering or specimen submission.

    • Molecular pathology/molecular genetic examples include many CPTs in the 812xx–814xx and 815xx ranges and U-codes (e.g., 0114U, 0129U, 0552U–0555U, 0560U–0561U)
    • Transplant and cardiology molecular tests (e.g., 81558, 81595) are included and managed by Carelon
    • New and retiring codes and effective-date changes are noted in the listing—check the code list for specifics and effective dates
    Prior Authorization

    Molecular/Genetic Tests Requiring Prior Authorization (Examples)

    Representative molecular/genetic tests requiring prior authorization include hereditary disease gene analyses, oncology next-generation sequencing panels, donor-derived cell-free DNA transplant monitoring assays, and preimplantation genetic testing panels. Carelon manages prior authorization for these tests—confirm code-level requirements and effective dates in the list.

    • Transplant monitoring and donor-derived cfDNA examples: 0508U, 0509U, 0540U
    • Oncology and MRD assays: 0306U, 0307U, 0379U, 0543U
    • Preimplantation and reproductive genomic assays: 0552U–0555U (added effective 10/01/2025)
    Prior Authorization

    Transplant / Cardiology Molecular Tests Prior Authorization

    Test types used in transplantation or cardiology monitoring (for example, gene expression and cell-free DNA assays used to assess rejection risk) require prior authorization and are managed by Carelon. Some transplant and cardiology assays have specific added effective dates — confirm prior to ordering.

    • Examples: 81558 (kidney transplant mRNA profiling), 81595 (cardiology/heart transplant gene expression profiling), multiple donor-derived cfDNA U-codes (e.g., 0508U, 0540U)
    • Carelon is the managing vendor for these transplant/cardiology molecular tests
    Note

    Prior Authorization Requirement and Vendor / Routing Notes

    Operational notes: many prior authorization requests for imaging, cardiology, and molecular/genetic tests are routed to Carelon. Some services remain managed by BCBSTX or were reassigned to Alacura (e.g., medical transportation). Always confirm the current managing vendor and use the appropriate prior authorization portal or phone number. Failing to obtain authorization from the correct vendor may result in claim denials.

    • Carelon is the primary vendor for advanced imaging, cardiology, and molecular/genetic prior authorizations in this list
    • Alacura manages certain medical transportation codes (e.g., A0430, A0435, S9960)
    • BCBSTX manages some ENT, cochlear, and home infusion codes—see listing for assignments
    • Confirm vendor and effective dates before submitting prior authorization requests
    ActionProviders must obtain prior authorization from Carelon for these codes before scheduling or performing services.
    Location where the service is performed, now required to be considered in medical necessity determinations
    Required factorSite of care (location where the service is performed) must be considered in medical necessity determinations for the listed CPT codes effective 01/01/2025.
    ExamplesAdvanced imaging codes such as 73206, 74182 and others explicitly note 'addition of site of care to the medical necessity criteria.'
    ImplicationAuthorization reviewers will consider the site-of-care when determining medical necessity for affected codes.
    Designated external review/vendor responsible for processing prior authorization requests for the listed CPT codes
    Designated external reviewerCarelon is identified as the external reviewer/vendor responsible for processing prior authorization requests for many listed CPT and PLA/U codes.
    ScopeCarelon is referenced across advanced imaging, cardiology, molecular pathology (81400–81410), and numerous U/PLA codes for prior authorization management.
    Provider instructionRoute prior authorization requests to Carelon where indicated by the code mapping in the list.
    Cardiac ultrasound studies including transthoracic and transesophageal exams and associated Doppler studies that require prior authorization
    Included studiesCardiac ultrasound studies requiring prior authorization include transthoracic and transesophageal echocardiography and associated Doppler studies (examples: 93303–93308, 93312–93317, 93320–93321, 93325, 93350–93351).
    Vendor mappingMany echocardiography/Doppler codes are assigned to Carelon for prior authorization review.
    Provider actionObtain prior authorization from the designated reviewer before scheduling these cardiac ultrasound procedures.
    Authorization vendor
    Authorization vendorAuthorization vendors referenced include Carelon and BCBSTX depending on the procedure group (Carelon for many imaging/genetics items; BCBSTX for selected ENT/home infusion items).
    ExamplesCarelon mapped to PET/MRI/CT and molecular genetics; BCBSTX mapped to home infusion (S9373, S9494) and cochlear implant codes.
    ImplicationCheck the vendor assignment per code when submitting prior authorization requests to ensure routing to the correct reviewer.
    Prior authorization requirement
    RequirementProcedures and supply/device codes listed (CPT/HCPCS/T-codes) require prior authorization before scheduling or billing as indicated in the document.
    ExamplesExamples include advanced imaging CPTs (0042T, 0633T), echocardiography CPTs (93303–93351), and device/supply HCPCS codes mapped to BCBSTX or Carelon.
    Provider instructionFollow the payer-specified initiation methods (searchable PDF, Blue Approve, or call the number on the member ID card) for submitting prior authorization requests.
    per diem
    Definition'Per diem' is used for home infusion administrative service billing codes (e.g., S9325, S9373, S9494) to denote daily administrative charges separate from drug/nursing charges.
    Billing noteSome per-diem codes must not be used with hourly codes or together when volume scales are specified (see code-specific guidance).
    Mapped vendorHome infusion per-diem codes are managed by BCBSTX in the listed entries.
    Carelon / Alacura
    Carelon / Alacura rolesCarelon and Alacura are named service/management entities: Carelon manages many molecular genetic testing prior authorizations; Alacura manages specified medical transportation (A0430, A0435, S9960) effective 01/01/2025.
    ExamplesA0430/A0435/S9960 management changed from BCBSTX to Alacura; numerous U-codes (0552U–0555U etc.) are assigned to Carelon with add-effective dates.
    ActionRoute prior authorization requests to the vendor identified for each specific code in the list.
    Carelon (designated prior authorization/review vendor for many listed molecular genetic tests)
    Carelon designationCarelon is the designated prior authorization/review vendor for many listed molecular genetic tests (numerous CPT and PLA/U entries reference Carelon as manager).
    ScopeCarelon assignment covers CPT ranges (e.g., 81203–81292), molecular pathology CPTs (81400–81410+), and extensive PLA/U code lists.
    Provider actionSubmit molecular genetic prior authorization requests to Carelon where the code entry specifies 'Carelon' as the manager.
    Molecular Pathology Procedure Level
    DefinitionMolecular Pathology Procedure Level: classification of tests by analytic scope (e.g., identification of a single germline variant by techniques such as restriction enzyme digestion or melt curve analysis for 81400).
    UseProcedure level guides CPT selection (81400–81407, 81410) based on analytic complexity and variant/exon coverage.
    Auth mappingCarelon is referenced alongside procedure-level CPT entries for authorization routing.
    Molecular Pathology Procedure Levels
    Levels summaryMolecular Pathology Procedure Levels categorize testing scope: Level 2 (2–10 SNPs/targeted analyses), Level 3 (>10 SNPs/LOH/UPD/STR/IG/TCR rearrangements), Level 4 (single exon or >10 amplicons), Level 5 (2–5 exons), Level 6 (6–10 exons), Level 7 (11–25 exons), Level 8 (26–50 exons or >50 exons).
    Clinical examplesLevel 3 entries reference UPD/LOH/STR analyses; level selection depends on variant/exon counts and methodology described in each CPT entry.
    AuthorizationCarelon is listed as reviewer for many procedure-level CPTs; select the appropriate level for prior authorization submission.
    Uniparental disomy / LOH / STR
    Tests includedUniparental disomy (UPD), loss of heterozygosity (LOH), and short tandem repeat (STR) analyses are referenced under molecular pathology procedure level 3 as specific analytic types used for certain syndromes and tumor analyses.
    ContextThese analytic approaches are included in level-3 descriptions alongside gene rearrangement and duplication/deletion analyses.
    Authorization implicationWhen UPD/LOH/STR testing is part of the panel, select the procedure level that reflects >10 SNPs or equivalent analytic complexity for prior authorization.
    Genomic Sequence Analysis Panel
    DefinitionGenomic Sequence Analysis Panel: a test interrogating specified genes by sequence analysis (may include duplication/deletion analysis, copy number variants, rearrangements, RNA analysis, or heteroplasmy detection) with required minimum gene counts as stated for each panel.
    ExamplesCodes reference panels such as hearing loss (≥60 genes, 81430), hereditary breast cancer (≥10 genes, 81432), and mitochondrial panels (≥100 genes, 81440 series).
    Prior authPanels must meet the code-specific minimum gene/content requirements for authorization and reviewer assessment (Carelon for many entries).
    Cell-free nucleic acid
    DefinitionCell-free nucleic acid: plasma-based circulating cell-free fetal or tumor DNA analyzed for sequence variants, copy number variants, and rearrangements when specified (referenced in codes such as 81462–81464).
    Examples81462–81464 describe cell-free nucleic acid panels interrogating sequence variants, CNVs, MSI, TMB and rearrangements for solid organ neoplasms.
    AuthorizationCarelon is listed as the reviewer for many cell-free nucleic acid assays; prior authorization should indicate specimen type and analytic scope.
    Carelon
    Carelon referenceCarelon is repeatedly named as the prior authorization manager/reviewer for many molecular genetic lab testing codes (multiple U-codes and 8xxxx CPTs list Carelon).
    ScopeCarelon is assigned across a broad set of molecular genetic test codes (examples: 0306U, 0500U, 0552U, 812xx series, 814xx series and many PLA/U codes).
    Provider actionSubmit molecular genetic prior authorization requests to Carelon when the code mapping indicates Carelon as the manager.
    Molecular genetic lab testing
    DefinitionMolecular genetic lab testing encompasses gene expression profiling, targeted sequencing, methylation analysis, microarray, whole exome/genome, and other genomic analyses using specimen types such as FFPE tissue, plasma (cell-free), blood, urine, or saliva.
    ReportingResults may be reported as algorithmic scores, recurrence risk, categorical results, presence/absence, or variant lists depending on the test.
    Authorization mappingMany molecular genetic lab testing CPT/PLA/U codes are routed to Carelon for prior authorization review per the document entries.
    authorization vendor specified for listed codes
    Auth vendor specifiedCarelon is specified as the authorization vendor/ reviewer for many listed molecular genetic codes (numerous U-codes and CPT entries note 'Carelon').
    ExamplesEntries such as 0267U, 0306U, 0500U, 0540U, and many 812xx/814xx CPTs explicitly list Carelon as manager.
    InstructionProviders must follow Carelon submission procedures for those codes and confirm any add/retire effective dates when present.
    Carelon
    Carelon as reviewerCarelon is listed multiple times as the prior authorization reviewer for molecular genetic and PLA/U codes across the document.
    ExamplesSpecific entries referencing Carelon include 0500U, 0506U, 0508U, 0543U, and many others in the U-code sections.
    ActionConfirm Carelon routing for codes before submission; follow vendor-specific documentation requirements.
    Molecular genetic lab testing codes
    Scope of codesMolecular genetic lab testing codes in the document include PLA/U codes, 8xxxx CPTs, and molecular pathology CPT ranges (examples: 81203–81292, 81400–81410, numerous U-codes).
    Prior auth stancePrior authorization is required for the listed molecular genetic lab testing codes; many entries indicate Carelon as the review vendor.
    Provider requirementWhen submitting prior authorization, include test methodology, gene/panel content, and specimen type as required by the code entry.
    Category label used repeatedly to classify many listed codes
    Category label'Molecular Genetic Lab Testing' is the repeated category label used to classify many listed CPT, PLA/U, and U-code entries.
    ExamplesThis category encompasses molecular pathology procedure levels, genomic panels, gene-expression assays, and PLA/U proprietary test codes listed across the document.
    Authorization mappingMost entries under this category reference Carelon for prior authorization review.
    Prior-authorization vendor referenced for review of listed procedures
    Designated prior-authorization vendorCarelon is the prior-authorization vendor referenced repeatedly for review of many molecular genetic tests and selected procedures; Alacura is referenced for specified medical transportation codes.
    ExamplesCarelon: molecular genetic U-codes and many 8xxxx CPTs; Alacura: A0430, A0435, S9960 (medical transportation) effective 01/01/2025.
    ActionRoute prior authorization requests to the vendor indicated by code-level mapping in the list to ensure correct processing.
    Instruction to list additional vertebral segments or interspaces separately in addition to primary procedure code when applicable
    InstructionList each additional vertebral segment or interspace separately in addition to the primary procedure code when applicable (e.g., 'Each Additional Interspace/Segment' entries for 22515, 22552, 22612, etc.).
    Examples22515 notes 'Each Additional Thoracic Or Lumbar Vertebral Body (List Separately In Addition To Code For Primary Procedure)'; 22552/22612 reference 'Each Additional Interspace'.
    Billing implicationInclude separate line items for additional segments/interspaces to reflect full operative scope for prior authorization and claim adjudication.